Intraocular implants of alpha-2 adrenergic receptor agonists and methods for improving vision

Details for Australian Patent Application No. 2011202200 (hide)

Owner Allergan, Inc.

Inventors Jackson, Brittany A.; Huang, Glenn; Burke, James; Lin, Ton; Wheeler, Larry A.; Hughes, Patrick M.; Donn, Rosy S.; Zhang, Kai-Ming

Agent Davies Collison Cave

Pub. Number AU-B-2011202200

Parent 2005244149

Filing date 12 May 2011

Wipo publication date 2 June 2011

Acceptance publication date 1 November 2012

International Classifications

A61K 9/00 Medicinal preparations characterised by special physical form

A61K 31/498 - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61P 27/02 Drugs for disorders of the senses

A61P 27/06 Drugs for disorders of the senses

Event Publications

2 June 2011 Application Open to Public Inspection

  Published as AU-B-2011202200

2 June 2011 Complete Application Filed

1 November 2012 Application Accepted

  Published as AU-B-2011202200

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011202201-Seawater desalination apparatus

2011202199-Downhole packer having tandem packer elements for isolating frac zones